Last reviewed · How we verify
Metastatic colorectal cancer
Approved treatments
Pipeline
- ZN-c3 · Pfizer Inc. — discontinued
- sunitinib and capecitabine · Pfizer Inc. — discontinued
- PHYTONADIONE — Phase 2
Clinical guidelines
- FDA label — 1L|2L
ZIRABEV, in combination with intravenous fluorouracil-based chemotherapy, is indicated for the first- or second-line treatment of patients with metastatic colorectal cancer (mCRC). - FDA label — 2L
ZIRABEV, in combination with fluoropyrimidine-irinotecan- or fluoropyrimidine-oxaliplatin-based chemotherapy, is indicated for the second-line treatment of patients with mCRC who have progressed on a first-line bevacizumab product-containing regimen. - FDA label — 1L|2L
MVASI, in combination with intravenous fluorouracil-based chemotherapy, is indicated for the first- or second-line treatment of patients with metastatic colorectal cancer (mCRC). - FDA label — 2L
MVASI, in combination with fluoropyrimidine-irinotecan- or fluoropyrimidine-oxaliplatin-based chemotherapy, is indicated for the second-line treatment of patients with mCRC who have progressed on a first-line bevacizumab product-containing regimen.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Metastatic colorectal cancer patent landscape — cliff calendar, originator estates, attackable patents
- Metastatic colorectal cancer treatment landscape brief
- Metastatic colorectal cancer treatment updates RSS
Frequently asked questions about Metastatic colorectal cancer
What drugs treat Metastatic colorectal cancer?
Tracked treatments include Folfiri, Folfox-7.
What is the treatment for Metastatic colorectal cancer?
Standard treatment for Metastatic colorectal cancer includes Folfiri, Folfox-7. See the treatment landscape page for first-line, second-line and salvage options.
What new drugs are in development for Metastatic colorectal cancer?
3 pipeline drugs tracked. Top candidates: ZN-c3, sunitinib and capecitabine, PHYTONADIONE.
What are the treatment guidelines for Metastatic colorectal cancer?
FDA label publishes guidelines for Metastatic colorectal cancer. 4 guideline references tracked.
Related
- Treatment landscape: Metastatic colorectal cancer patent cliff · Metastatic colorectal cancer CI report
- Treatment: Folfiri · Pfizer
- Treatment: Folfox-7 · Pfizer
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing